2m 2m 2m 2m 2m 2m 2m
ZENAS BIOPHARMA (ZBIO)
NASDAQ
$32.31+$0.02 (+0.06%)
Price as of Aug 21, 2026 7:42 PM EDT- $2.1BMarket Cap
- 88.83%1-Year Change
- BiotechnologyIndustry
ZENAS BIOPHARMA (ZBIO)
$32.31+$0.02 (+0.06%)
ZBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.29 | ||
Change | +$0.67 (+2.12%) | ||
Open | $31.83 | ||
High | $32.79 | ||
Low | $31.45 | ||
Previous Close | $31.62 | ||
Volume | 808,718 | ||
30-Day Average Volume | 756,464 | ||
1-Week Change | 9.42% | ||
1-Month Change | -0.22% | ||
1-Year Change | 88.83% | ||
3-Year Change | 222.24% | ||
5-Year Change | 222.24% | ||
Fundamentals | |||
Shares Outstanding | 65.2M | ||
Total Assets | $701.7M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.2B | ||
Period: QTR TTM FY | |||
Revenue | $1.0M | ||
Net Income | -$111.5M | ||
Free Cash Flow | -$57.2M | ||
EBIT | -$109.6M | ||
EBITDA | -$109.6M | ||
Net Working Capital | $588.0M | ||
EPS | -$1.77 | ||
Enterprise Value/EBITDA | -20 | ||
Enterprise Value/Revenue | 2,205 | ||
P/B | 9 | ||
P/E | -18 | ||
PEG | 1 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 12/24/2019 | ||
Last Split Factor | 1 : 2 | ||
Last Split Date | 05/24/2018 | ||
Earnings & Revenue